Target type: cellularcomponent
An integrin complex that comprises one alphav subunit and one beta6 subunit. [PMID:12297042]
The integrin alphav-beta6 complex is a transmembrane protein complex that is primarily localized to the cell surface, specifically within the plasma membrane. It acts as a key adhesion receptor mediating cell-cell and cell-extracellular matrix interactions. The cellular component of this complex can be described as follows:
1. **Plasma membrane:** The integrin alphav-beta6 complex is embedded within the plasma membrane, with its extracellular domains extending outside the cell and its cytoplasmic domains interacting with intracellular signaling molecules.
2. **Focal adhesions:** Integrin alphav-beta6 complexes often cluster at specialized structures called focal adhesions, which are sites of cell-matrix adhesion. These adhesions are dynamic assemblies of proteins that link the cytoskeleton to the extracellular matrix, facilitating cell migration, growth, and differentiation.
3. **Cytoplasm:** The cytoplasmic domains of alphav and beta6 subunits interact with a variety of intracellular signaling molecules. These interactions play a crucial role in mediating downstream signaling pathways, including those involved in cell proliferation, survival, and migration.
4. **Extracellular matrix:** The extracellular domains of alphav and beta6 subunits bind to specific ligands within the extracellular matrix, such as the latent transforming growth factor beta (TGF-beta) and the fibronectin. These interactions are essential for regulating cell behavior and tissue homeostasis.
5. **Other cellular components:** In addition to these primary components, integrin alphav-beta6 complexes may also interact with other cellular structures, including the cytoskeleton, the nucleus, and specific organelles. These interactions contribute to the diverse functions of this complex in various cellular processes.
In summary, the cellular component of the integrin alphav-beta6 complex encompasses the plasma membrane, focal adhesions, cytoplasm, and extracellular matrix. This complex plays a vital role in mediating cell adhesion, signaling, and various cellular processes.'
"
Protein | Definition | Taxonomy |
---|---|---|
Integrin beta-6 | An integrin beta-6 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P18564] | Homo sapiens (human) |
Integrin alpha-V | An integrin alpha-V that is encoded in the genome of human. [PRO:DNx, UniProtKB:P06756] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
1-(3-chlorophenyl)biguanide | 1-(3-chlorophenyl)biguanide: RN given refers to parent cp; a 5-HT3 receptor agonist | biguanides; monochlorobenzenes | |
phenyl biguanide | phenyl biguanide : A member of the class of biguanides that is biguanide in which one of the terminal nitrogen atoms is substituted by a phenyl group. phenyl biguanide: RN given refers to parent cpd | guanidines | central nervous system drug |
4-chlorophenylbiguanide | |||
paclitaxel | Taxus: Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL). | taxane diterpenoid; tetracyclic diterpenoid | antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent |
tirofiban | tirofiban : A member of the class of piperidines that is L-tyrosine in which a hydrogen attached to the amino group is replaced by a butylsulfonyl group and in which the hydrogen attached to the phenolic hydroxy group is replaced by a 4-(piperidin-4-yl)butyl group. Tirofiban: Tyrosine analog and PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX antagonist that inhibits PLATELET AGGREGATION and is used in the treatment of ACUTE CORONARY SYNDROME. | L-tyrosine derivative; piperidines; sulfonamide | anticoagulant; fibrin modulating drug; platelet glycoprotein-IIb/IIIa receptor antagonist |
25-hydroxycholesterol | 25-hydroxy steroid; oxysterol | human metabolite | |
tetraiodothyroacetic acid | 3,3',5,5'-tetraiodothyroacetic acid : A monocarboxylic acid that is thyroacetic acid carrying four iodo substituents at positions 3, 3', 5 and 5'. tetraiodothyroacetic acid: RN given refers to parent cpd; structure | 2-halophenol; aromatic ether; iodophenol; monocarboxylic acid | apoptosis inducer; human metabolite; thyroid hormone |
arginyl-glycyl-aspartic acid | arginyl-glycyl-aspartic acid: amino acid sequence of basic unit of widespread cellular recognition system | oligopeptide | |
glycyl-arginyl-glycyl-aspartyl-serine | glycyl-arginyl-glycyl-aspartyl-serine: synthetic peptide from fibronectins; inhibits experimental metastasis of murine melanoma cells | ||
glycyl- arginyl-glycyl-aspartyl-seryl-prolyl-lysine | |||
d-arg-gly-asp-trp | arginyl-glycyl-aspartyl-tryptophan: a synthetic RGD-containing peptide | ||
l 738167 | L 738167: structure in first source | ||
sk&f 107260 | SK&F 107260: structure given in first source | ||
cilengitide | Cilengitide: an alphaVbeta3 integrin antagonist that paralyzes cancer cells | oligopeptide | |
l 734217 | L 734217: fibrinogen receptor antagonist; structure given in first source | ||
elarofiban | elarofiban: a GPIIb and GPIIIa receptor antagonist; structure in first source | ||
eptifibatide | homodetic cyclic peptide; macrocycle; organic disulfide | anticoagulant; platelet aggregation inhibitor | |
arginyl-glycyl-aspartyl-phenylalanine | |||
sb 223245 | |||
cyclic(arg-gly-asp-d-phe-val) | |||
mk-0429 | |||
sb 273005 |